File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1109/IEMBS.2009.5334210
- Scopus: eid_2-s2.0-77951002860
- PMID: 19964849
- WOS: WOS:000280543603288
- Find via
Supplementary
- Citations:
- Appears in Collections:
Conference Paper: Manganese-enhanced MRI of hypoxic-ischemic brain injuries using Mn-DPDP
Title | Manganese-enhanced MRI of hypoxic-ischemic brain injuries using Mn-DPDP |
---|---|
Authors | |
Keywords | Brain injury Clinical diagnosis Contrast agent Hypointensity Image contrasts |
Issue Date | 2009 |
Publisher | IEEE. The Journal's web site is located at http://www.ieeexplore.ieee.org/xpl/conhome.jsp?punumber=1000269 |
Citation | The 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2009), Minneapolis, MN., 3-6 September 2009. In Proceedings of the 31st EMBC, 2009, p. 4775-4778 How to Cite? |
Abstract | In this study, Mn-dipyridoxaldiphosphate (MnDPDP), a clinically approved manganese contrast agent for hepatic and pancreatic imaging, was demonstrated for the first time for manganese-enhanced MRI (MEMRI) in brains of normal young rats (n=4) and rats with hypoxic-ischemic (H-I) insult at postnatal day 7 (n=8). After a single intraperitoneal injection of low dosage with 0.1μmol/g in postnatal 14 days, 2D T1-weighted image (T1WIs), T1 maps, T2-weighted images (T2WIs) and T2 maps were acquired at 7 Tesla 1 day before, 1 day and 7 days after MnDPDP injection. The image contrast changes induced by MnDPDP appeared as the hyperintensity in T1WIs and the hypointensity in T2WIs. T1and T2 values decreased in the regions of Mn enhancement. Such enhancement presented as a delayed pattern that was more pronounced in 7 day after MnDPDP injection, suggesting the sustained Mn accumulation due to MnDPDP. Moreover, the MnDPDP enhancement in H-I brains was more pronounced in the lesion sites and was easily detectable in T1WI, T1 map, T2WI and T2 map. The results demonstrated here support the possibility of using MnDPDP as a 'slow release' Mn2+ for clinical diagnosis of various neuropathologies. ©2009 IEEE. |
Description | Theme: Engineering the Future of Biomedicine |
Persistent Identifier | http://hdl.handle.net/10722/129726 |
ISSN | 2020 SCImago Journal Rankings: 0.282 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, J | en_HK |
dc.contributor.author | Wu, EX | en_HK |
dc.date.accessioned | 2010-12-23T08:41:18Z | - |
dc.date.available | 2010-12-23T08:41:18Z | - |
dc.date.issued | 2009 | en_HK |
dc.identifier.citation | The 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2009), Minneapolis, MN., 3-6 September 2009. In Proceedings of the 31st EMBC, 2009, p. 4775-4778 | en_HK |
dc.identifier.issn | 1557-170X | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/129726 | - |
dc.description | Theme: Engineering the Future of Biomedicine | - |
dc.description.abstract | In this study, Mn-dipyridoxaldiphosphate (MnDPDP), a clinically approved manganese contrast agent for hepatic and pancreatic imaging, was demonstrated for the first time for manganese-enhanced MRI (MEMRI) in brains of normal young rats (n=4) and rats with hypoxic-ischemic (H-I) insult at postnatal day 7 (n=8). After a single intraperitoneal injection of low dosage with 0.1μmol/g in postnatal 14 days, 2D T1-weighted image (T1WIs), T1 maps, T2-weighted images (T2WIs) and T2 maps were acquired at 7 Tesla 1 day before, 1 day and 7 days after MnDPDP injection. The image contrast changes induced by MnDPDP appeared as the hyperintensity in T1WIs and the hypointensity in T2WIs. T1and T2 values decreased in the regions of Mn enhancement. Such enhancement presented as a delayed pattern that was more pronounced in 7 day after MnDPDP injection, suggesting the sustained Mn accumulation due to MnDPDP. Moreover, the MnDPDP enhancement in H-I brains was more pronounced in the lesion sites and was easily detectable in T1WI, T1 map, T2WI and T2 map. The results demonstrated here support the possibility of using MnDPDP as a 'slow release' Mn2+ for clinical diagnosis of various neuropathologies. ©2009 IEEE. | en_HK |
dc.language | eng | en_US |
dc.publisher | IEEE. The Journal's web site is located at http://www.ieeexplore.ieee.org/xpl/conhome.jsp?punumber=1000269 | - |
dc.relation.ispartof | Proceedings of the Annual International Conference of the IEEE Engineering In Medicine And Biology Society, EMBC 2009 | en_HK |
dc.rights | ©2009 IEEE. Personal use of this material is permitted. However, permission to reprint/republish this material for advertising or promotional purposes or for creating new collective works for resale or redistribution to servers or lists, or to reuse any copyrighted component of this work in other works must be obtained from the IEEE. | - |
dc.subject | Brain injury | - |
dc.subject | Clinical diagnosis | - |
dc.subject | Contrast agent | - |
dc.subject | Hypointensity | - |
dc.subject | Image contrasts | - |
dc.subject.mesh | Animals | en_HK |
dc.subject.mesh | Animals, Newborn | en_HK |
dc.subject.mesh | Contrast Media - chemistry - diagnostic use | en_HK |
dc.subject.mesh | Edetic Acid - analogs & derivatives - chemistry - diagnostic use | en_HK |
dc.subject.mesh | Female | en_HK |
dc.subject.mesh | Hypoxia-Ischemia, Brain - diagnosis | en_HK |
dc.subject.mesh | Magnetic Resonance Imaging - methods | en_HK |
dc.subject.mesh | Manganese - chemistry | en_HK |
dc.subject.mesh | Pregnancy | en_HK |
dc.subject.mesh | Pyridoxal Phosphate - analogs & derivatives - chemistry - diagnostic use | en_HK |
dc.subject.mesh | Rats | en_HK |
dc.subject.mesh | Rats, Sprague-Dawley | en_HK |
dc.title | Manganese-enhanced MRI of hypoxic-ischemic brain injuries using Mn-DPDP | en_HK |
dc.type | Conference_Paper | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1557-170X&volume=&spage=4775&epage=4778&date=2009&atitle=Manganese-enhanced+MRI+of+hypoxic-ischemic+brain+injuries+using+Mn-DPDP | - |
dc.identifier.email | Wu, EX:ewu1@hkucc.hku.hk | en_HK |
dc.identifier.authority | Wu, EX=rp00193 | en_HK |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1109/IEMBS.2009.5334210 | en_HK |
dc.identifier.pmid | 19964849 | - |
dc.identifier.scopus | eid_2-s2.0-77951002860 | en_HK |
dc.identifier.hkuros | 178156 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-77951002860&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.spage | 4775 | en_HK |
dc.identifier.epage | 4778 | en_HK |
dc.identifier.isi | WOS:000280543603288 | - |
dc.publisher.place | United States | en_HK |
dc.description.other | The 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2009), Minneapolis, MN., 3-6 September 2009. In Proceedings of the 31st EMBC, 2009, p. 4775-4778 | - |
dc.identifier.scopusauthorid | Yang, J=10041733800 | en_HK |
dc.identifier.scopusauthorid | Wu, EX=7202128034 | en_HK |
dc.identifier.issnl | 1557-170X | - |